Search Results 511-520 of 19683 for Hepatitis+C

  1. A Study to Assess the Efficacy and Safety of Risankizumab in Subjects With Moderately to Severely Active Crohn's Disease Who Failed Prior Biologic Treatment - Mayo Clinic

    Have active hepatitis B or hepatitis C defined as: HBV: hepatitis B surface ... hepatitis B core antibody (HBc Ab) positive subjects;; HCV: HCV ...

  2. Joel Streed | Mayo Clinic News Network - Page 93 of 170

    Joel Streed (@JoelStreed). Fecal Microbiota Transplant / Living Donor Kidney Program / Hepatitis C: Mayo Clinic Radio. Imagine a gut bacteria so strong that ...

  3. Housecall: Understanding your risk of osteoporosis - Mayo Clinic News Network

    Anyone concerned about liver health should avoid alcohol, including those who have undergone successful treatment for hepatitis C. Learn more from Dr ...

  4. Stacey A. Rizza, M.D. - Doctors and Medical Staff - Mayo Clinic

    Work GroupHepatitis C Curriculum, Infectious Diseases Society of America. 2012. Scientific ReviewerNational Institutes of Health. 2012. Scientific ReviewerRFA ...

  5. Hodgkin lymphoma (Hodgkin disease) - Diagnosis and treatment - Mayo Clinic

    Blood tests may be used to test for viruses, including HIV, EBV, hepatitis B virus and hepatitis C virus. ... hepatitis C, some treatments can cause the virus to ...

  6. Mayo Clinic Q & A - 2024 Archives

    Mayo Clinic Q and A: Understanding hepatitis C featured image. Mayo Clinic Q and A: Understanding hepatitis C. Joel Streed. November 9, 2024.

  7. Fatigue Causes - Mayo Clinic

    Hepatitis B · Hepatitis C · HIV/AIDS · Hyperthyroidism (overactive thyroid) · Hypothyroidism (underactive thyroid) · Inflammatory bowel disease (IBD) · Liver ...

  8. Study Comparing Tarlatamab and Durvalumab Versus Durvalumab Alone in First-Line Extensive-Stage Small-Cell Lung Cancer (ES-SCLC) Following Platinum, Etoposide and Durvalumab (DeLLphi-305) - Mayo Clinic

    ... c\]), or T3 to T4 due to multiple lung nodules that are too extensive or ... hepatitis C infection (participants with hepatitis C that achieve a ...

  9. Mayo Clinic Q & A - 2024 Archives

    Mayo Clinic Q and A: Understanding hepatitis C featured image. Mayo Clinic Q and A: Understanding hepatitis C. Joel Streed. November 9, 2024.

  10. A Study to Determine Dose, Safety, and Efficacy of Durvalumab as Monotherapy and in Combination Therapy in Subjects With Lymphoma or Chronic Lymphocytic Leukemia - Mayo Clinic

    Arms C only: bendamustine ... Subject who has known seropositivity for or active infection for human immunodeficiency virus (HIV) or hepatitis C virus (HCV).